LINQ for impEdance meAsuremeNt While Off From HF Medication Study

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

April 30, 2019

Conditions
Heart Failure
Interventions
DRUG

Diuretic Suspension (DS)

Stop diuretic consumption in the 48h before the follow-up visit

DRUG

Diuretic Increase (DI)

Double diuretics dosage in the 48h before the follow-up visit

DRUG

Diuretic and Medication Suspension (DMS)

Stop diuretic and MRA medication consumption in the 48h before the follow-up visit

Trial Locations (1)

G12 0XH

RECRUITING

Nhs Greater Glasgow & Clyde, Glasgow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic BRC

INDUSTRY

NCT03245281 - LINQ for impEdance meAsuremeNt While Off From HF Medication Study | Biotech Hunter | Biotech Hunter